Mark J. Coster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark J. Coster has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
- Michael Kassiou
University of Sydney
9 shared publications - Rohan A. Davis
Institute for Biomedicine and Glycomics, Griffith University, Brisbane, QLD 4111, Australiahttps://ror.org/02sc3r913https://www.isni.org/isni
7 shared publications - Martin Gerhardt Banwell
Guangdong Key Laboratory for Research and the Development of Natural Drugs The Marine Biomedical Research Institute Guangdong Medical University Zhanjiang Guangdong 524023 China
6 shared publications - Andreas Hofmann
The University of Melbourne
5 shared publications David Y.-K. Chen
University Chemical Laboratory, Lensfield Road, University of Cambridge, Cambridge, UK
5 shared publications- Ian Paterson
University Chemical Laboratory, University of Cambridge, UK
5 shared publications
Latest Publications
- Open Access
Synthesis of New Triazolopyrazine Antimalarial Compounds
A radical approach to late-stage functionalization using photoredox and Diversinate™ chemistry on the Open Source Malaria (OSM) triazolopyrazine scaffold (Series 4) resulted in the synthesis of 12 new analogues, which were characterized by NMR, UV, and MS data analysis. The structures of four triazolopyrazines were confirmed by X-ray crystal structure analysis. Several minor and unexpected side products were generated during these studies, including two resulting from a possible disproportionation reaction. All compounds were tested for their ability to inhibit the growth of the malaria parasite Plasmodium falciparum (3D7 and Dd2 strains) and for cytotoxicity against a human embryonic kidney (HEK293) cell line. Moderate antimalarial activity was observed for some of the compounds, with IC50 values ranging from 0.3 to >20 µM; none of the compounds displayed any toxicity against HEK293 at 80 µM.
Open AccessSynthesis of New Triazolopyrazine Antimalarial Compounds
A radical approach to late-stage functionalization using photoredox and Diversinate™ chemistry on the Open Source Malaria (OSM) triazolopyrazine scaffold (Series 4) resulted in the synthesis of 12 new analogues, which were characterized by NMR, UV, and MS data analysis. The structures of four triazolopyrazines were confirmed by X-ray crystal structure analysis. Several minor and unexpected side products were generated during these studies, including two resulting from a possible disproportionation reaction. All compounds were tested for their ability to inhibit the growth of the malaria parasite Plasmodium falciparum (3D7 and Dd2 strains) and for cytotoxicity against a human embryonic kidney (HEK293) cell line. Moderate antimalarial activity was observed for some of the compounds, with IC50 values ranging from 0.3 to >20 µM; none of the compounds displayed any toxicity against HEK293 at 80 µM.
- Open Access
Reaction of Papaverine with Baran DiversinatesTM
The reaction of papaverine with a series of Baran DiversinatesTM is reported. Although the yields were low, it was possible to synthesize a small biodiscovery library using this plant alkaloid as a scaffold for late-stage C–H functionalization. Ten papaverine analogues (2–11), including seven new compounds, were synthesized. An unexpected radical-induced exchange reaction is reported where the dimethoxybenzyl group of papaverine was replaced by an alkyl group. This side reaction enabled the synthesis of additional novel fragments based on the isoquinoline scaffold, which is present in numerous natural products. Possible reasons for the poor yields in the DiversinateTM reactions with this particular scaffold are discussed.
Open AccessReaction of Papaverine with Baran DiversinatesTM
The reaction of papaverine with a series of Baran DiversinatesTM is reported. Although the yields were low, it was possible to synthesize a small biodiscovery library using this plant alkaloid as a scaffold for late-stage C–H functionalization. Ten papaverine analogues (2–11), including seven new compounds, were synthesized. An unexpected radical-induced exchange reaction is reported where the dimethoxybenzyl group of papaverine was replaced by an alkyl group. This side reaction enabled the synthesis of additional novel fragments based on the isoquinoline scaffold, which is present in numerous natural products. Possible reasons for the poor yields in the DiversinateTM reactions with this particular scaffold are discussed.
- Open Access
- 30 August 2019
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 22 (2) , 216-228
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore
Background: Despite significant endeavor having been applied to identify effective therapies to treat glioblastoma (GBM), survival outcomes remain intractable. The greatest nonsurgical benefit arises from radiotherapy, though tumors typically recur due to robust DNA repair. Patients could therefore benefit from therapies with the potential to prevent DNA repair and synergize with radiotherapy. In this work, we investigated the potential of salinomycin to enhance radiotherapy and further uncover novel dual functions of this ionophore to induce DNA damage and prevent repair. Methods: In vitro primary GBM models and ex vivo GBM patient explants were used to determine the mechanism of action of salinomycin by immunoblot, flow cytometry, immunofluorescence, immunohistochemistry, and mass spectrometry. In vivo efficacy studies were performed using orthotopic GBM animal xenograft models. Salinomycin derivatives were synthesized to increase drug efficacy and explore structure-activity relationships. Results: Here we report novel dual functions of salinomycin. Salinomycin induces toxic DNA lesions and prevents subsequent recovery by targeting homologous recombination (HR) repair. Salinomycin appears to target the more radioresistant GBM stem cell–like population and synergizes with radiotherapy to significantly delay tumor formation in vivo. We further developed salinomycin derivatives which display greater efficacy in vivo while retaining the same beneficial mechanisms of action. Conclusion: Our findings highlight the potential of salinomycin to induce DNA lesions and inhibit HR to greatly enhance the effect of radiotherapy. Importantly, first-generation salinomycin derivatives display greater efficacy and may pave the way for clinical testing of these agents.
- 30 August 2019
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 22 (2) , 216-228
Open AccessSimultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore
Background: Despite significant endeavor having been applied to identify effective therapies to treat glioblastoma (GBM), survival outcomes remain intractable. The greatest nonsurgical benefit arises from radiotherapy, though tumors typically recur due to robust DNA repair. Patients could therefore benefit from therapies with the potential to prevent DNA repair and synergize with radiotherapy. In this work, we investigated the potential of salinomycin to enhance radiotherapy and further uncover novel dual functions of this ionophore to induce DNA damage and prevent repair. Methods: In vitro primary GBM models and ex vivo GBM patient explants were used to determine the mechanism of action of salinomycin by immunoblot, flow cytometry, immunofluorescence, immunohistochemistry, and mass spectrometry. In vivo efficacy studies were performed using orthotopic GBM animal xenograft models. Salinomycin derivatives were synthesized to increase drug efficacy and explore structure-activity relationships. Results: Here we report novel dual functions of salinomycin. Salinomycin induces toxic DNA lesions and prevents subsequent recovery by targeting homologous recombination (HR) repair. Salinomycin appears to target the more radioresistant GBM stem cell–like population and synergizes with radiotherapy to significantly delay tumor formation in vivo. We further developed salinomycin derivatives which display greater efficacy in vivo while retaining the same beneficial mechanisms of action. Conclusion: Our findings highlight the potential of salinomycin to induce DNA lesions and inhibit HR to greatly enhance the effect of radiotherapy. Importantly, first-generation salinomycin derivatives display greater efficacy and may pave the way for clinical testing of these agents.
- 18 April 2019
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 96 (6) , 1262-1267
Disseminating a Free, Practical Java Tool To Interactively Generate and Edit 2D Chemical Structures
- 18 April 2019
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 96 (6) , 1262-1267
Disseminating a Free, Practical Java Tool To Interactively Generate and Edit 2D Chemical Structures
- Open Access
- 1 March 2018
- Published by Elsevier in Tetrahedron
- Vol. 74 (12) , 1313-1321
Stereoselective bidirectional synthesis of spiroacetals via Rh(II)-catalysed double C–H insertion
- 1 March 2018
- Published by Elsevier in Tetrahedron
- Vol. 74 (12) , 1313-1321
Open AccessStereoselective bidirectional synthesis of spiroacetals via Rh(II)-catalysed double C–H insertion
- 5 December 2017
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (2) , 256-261
Synthesis of spirocyclic orthoesters by ‘anomalous’ rhodium(ii)-catalysed intramolecular C–H insertions
A tetrahydropyranyl acetal bearing a proximal phenyl diazoketone substituent underwent Rh(II)-catalysed C–H insertion via an ‘anomalous’ C–O bond-forming, rather than C–C bond-forming, transformation, giving spirocyclic orthoesters. Density functional theory calculations with M06 show that the formation of these anomalous products involves hydride transfer to the rhodium carbene, giving an intermediate zwitterion which undergoes C–O bond formation in preference to C–C bond formation.
- 5 December 2017
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 16 (2) , 256-261
Synthesis of spirocyclic orthoesters by ‘anomalous’ rhodium(ii)-catalysed intramolecular C–H insertions
A tetrahydropyranyl acetal bearing a proximal phenyl diazoketone substituent underwent Rh(II)-catalysed C–H insertion via an ‘anomalous’ C–O bond-forming, rather than C–C bond-forming, transformation, giving spirocyclic orthoesters. Density functional theory calculations with M06 show that the formation of these anomalous products involves hydride transfer to the rhodium carbene, giving an intermediate zwitterion which undergoes C–O bond formation in preference to C–C bond formation.
- 1 July 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (14) , 3185-3189
The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid
- 1 July 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (14) , 3185-3189
The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid
- Open Access
- 17 May 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Enzyme characteristics of pathogen-specific trehalose-6-phosphate phosphatases
Owing to the key role of trehalose in pathogenic organisms, there has recently been growing interest in trehalose metabolism for therapeutic purposes. Trehalose-6-phosphate phosphatase (TPP) is a pivotal enzyme in the most prominent biosynthesis pathway (OtsAB). Here, we compare the enzyme characteristics of recombinant TPPs from five important nematode and bacterial pathogens, including three novel members of this protein family. Analysis of the kinetics of trehalose-6-phosphate hydrolysis reveals that all five enzymes display a burst-like kinetic behaviour which is characterised by a decrease of the enzymatic rate after the pre-steady state. The observed super-stoichiometric burst amplitudes can be explained by multiple global conformational changes in members of this enzyme family during substrate processing. In the search for specific TPP inhibitors, the trapping of the complex conformational transitions in TPPs during the catalytic cycle may present a worthwhile strategy to explore.
- 17 May 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Open AccessEnzyme characteristics of pathogen-specific trehalose-6-phosphate phosphatases
Owing to the key role of trehalose in pathogenic organisms, there has recently been growing interest in trehalose metabolism for therapeutic purposes. Trehalose-6-phosphate phosphatase (TPP) is a pivotal enzyme in the most prominent biosynthesis pathway (OtsAB). Here, we compare the enzyme characteristics of recombinant TPPs from five important nematode and bacterial pathogens, including three novel members of this protein family. Analysis of the kinetics of trehalose-6-phosphate hydrolysis reveals that all five enzymes display a burst-like kinetic behaviour which is characterised by a decrease of the enzymatic rate after the pre-steady state. The observed super-stoichiometric burst amplitudes can be explained by multiple global conformational changes in members of this enzyme family during substrate processing. In the search for specific TPP inhibitors, the trapping of the complex conformational transitions in TPPs during the catalytic cycle may present a worthwhile strategy to explore.
- 12 May 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (6) , 1318-1321
Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c
This study reports the most active non-sulfonamide mycobacterial CA inhibitor to date.
- 12 May 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (6) , 1318-1321
Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c
This study reports the most active non-sulfonamide mycobacterial CA inhibitor to date.
- 24 March 2017
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 53 (30) , 4219-4221
A bidirectional synthesis of spiroacetals via Rh(ii)-catalysed C–H insertion
Acyclic methylene acetals bearing two diazoester subunits have been converted to [5,5]-spiroacetals VIA bidirectional C–H insertion under Rh(II) catalysis. Using a chiral Rh(II) catalyst, the major diastereomer can be produced in high enantiomeric excess (89%).
- 24 March 2017
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 53 (30) , 4219-4221
A bidirectional synthesis of spiroacetals via Rh(ii)-catalysed C–H insertion
Acyclic methylene acetals bearing two diazoester subunits have been converted to [5,5]-spiroacetals VIA bidirectional C–H insertion under Rh(II) catalysis. Using a chiral Rh(II) catalyst, the major diastereomer can be produced in high enantiomeric excess (89%).